Chemours (CC) Stock Price, News & Analysis

Company Overview

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for electronics, communications, transportation, wire and cable, energy, oil and gas, and medical, and other applications under the eflon, Viton, Krytox, and Nafion brands. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

Key Stats

• Today's Range: $12.14 to $12.73
• 50-Day Range: $9.59 to $17.56
• 52-Week Range: $9.33 to $29.21
• Volume: 1.97 million shs
• Average Volume: 1.87 million shs
• Market Capitalization: $1.84 billion
• P/E Ratio: 21.60
• Dividend Yield: 8.12%
• Price Target: $21.56
• Consensus Rating: Moderate Buy

Chemours Stock Analysis - MarketRank™

Chemours scored higher than 80% of companies evaluated by MarketBeat, and ranked 38th out of 186 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Chemours has received a consensus rating of Moderate Buy. The company's average rating score is 2.56, and is based on 5 buy ratings, 4 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Chemours has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 33.50%

Earnings Growth

Earnings for Chemours are expected to grow by 33.50% in the coming year, from $2.03 to $2.71 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Chemours is 21.60, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 21.75.

Price to Earnings Ratio vs. Sector

The P/E ratio of Chemours is 21.60, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 74.97.

Price to Book Value per Share Ratio

Chemours has a P/B Ratio of 3.04. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

8.91% of the float of Chemours has been sold short.

Short Interest Ratio / Days to Cover

Chemours has a short interest ratio ("days to cover") of 4.5.

Change versus previous month

Short interest in Chemours has recently increased by 2.88%, indicating that investor sentiment is decreasing.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

Chemours is a leading dividend payer. It pays a dividend yield of 8.08%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Chemours does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Chemours is 175.44%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, Chemours will have a dividend payout ratio of 36.90% next year. This indicates that Chemours will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

8.91% of the float of Chemours has been sold short.

Short Interest Ratio / Days to Cover

Chemours has a short interest ratio ("days to cover") of 4.5.

Change versus previous month

Short interest in Chemours has recently increased by 2.88%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 3.8 / 5
• News Sentiment: 0.91

News Sentiment

Chemours has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Basic Materials companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for Chemours this week, compared to 7 articles on an average week.

Search Interest

12 people have searched for CC on MarketBeat in the last 30 days. This is an increase of 71% compared to the previous 30 days.

MarketBeat Follows

5 people have added Chemours to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Chemours insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.47% of the stock of Chemours is held by insiders.

Percentage Held by Institutions

76.26% of the stock of Chemours is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CC Stock Analysis - Frequently Asked Questions

How have CC shares performed this year?

Chemours' stock was trading at $16.90 at the beginning of the year. Since then, CC stock has decreased by 27.2% and is now trading at $12.31.
View the best growth stocks for 2025 here.

How were Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) posted its quarterly earnings data on Tuesday, February, 18th. The specialty chemicals company reported $0.11 EPS for the quarter, topping the consensus estimate of $0.10 by $0.01. The specialty chemicals company earned $1.36 billion during the quarter, compared to the consensus estimate of $1.37 billion. Chemours had a trailing twelve-month return on equity of 26.54% and a net margin of 1.51%.
Read the conference call transcript.

Who are Chemours' major shareholders?

Chemours' top institutional investors include Principal Financial Group Inc. (0.50%), Folger Nolan Fleming Douglas Capital Management Inc. (0.44%), Rhumbline Advisers (0.23%) and Peregrine Capital Management LLC (0.22%). Insiders that own company stock include Sameer Ralhan, Mark Newman, Edwin C Sparks, Alisha Bellezza, Matthew S Abbott, Diane I Picho and Alvenia Scarborough.
View institutional ownership trends.

How do I buy shares of Chemours?

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Chemours investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), AT&T (T), Tesla (TSLA), Chevron (CVX) and JPMorgan Chase & Co. (JPM).

Company Calendar

• Last Earnings: 2/18/2025
• Record date for 3/14 Dividend: 2/28/2025
• Ex-Dividend for 3/14 Dividend: 2/28/2025
• Dividend Payable: 3/14/2025
• Today: 4/28/2025
• Next Earnings (Estimated): 5/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Basic Materials
• Industry: Chemicals & allied products
• Sub-Industry: Chemicals
• Current Symbol: NYSE:CC
• CIK: 1627223
• Web: www.chemours.com
• Phone: (302) 773-1000
• Fax: N/A
• Employees: 6,600
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $21.56
• High Stock Price Target: $28.00
• Low Stock Price Target: $15.00
• Potential Upside/Downside: +75.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.56
• Research Coverage: 9 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $0.57
• Trailing P/E Ratio: 21.60
• Forward P/E Ratio: 6.06
• P/E Growth: N/A
• Net Income: $-238,000,000.00
• Net Margins: 1.51%
• Pretax Margin: 2.20%
• Return on Equity: 26.54%
• Return on Assets: 2.41%

Debt

• Debt-to-Equity Ratio: 6.70
• Current Ratio: 1.68
• Quick Ratio: 0.92

Sales & Book Value

• Annual Sales: $5.78 billion
• Price / Sales: 0.32
• Cash Flow: $2.60 per share
• Price / Cash Flow: 4.74
• Book Value: $4.05 per share
• Price / Book: 3.04

Miscellaneous

• Outstanding Shares: 149,441,000
• Free Float: 148,739,000
• Market Cap: $1.84 billion
• Optionable: Optionable
• Beta: 1.84